fortress
biotech
participate
three
september
virtual
investor
conferences
new
york
globe
newswire
fortress
biotech
nasdaq
fbio
fortress
innovative
company
focused
acquiring
developing
commercializing
monetizing
promising
biopharmaceutical
products
product
candidates
today
announced
lindsay
rosenwald
chairman
president
chief
executive
officer
participate
three
virtual
investor
conferences
september
company
also
host
virtual
meetings
conferences
details
events
follows
wainwright
nd
annual
global
investment
conference
fireside
chat
monday
september
edt
annual
global
investment
conference
fireside
chat
monday
september
edt
cantor
virtual
global
healthcare
conference
fireside
chat
wednesday
september
edt
oppenheimer
fall
healthcare
life
sciences
medtech
summit
presentation
tuesday
september
edt
live
webcasts
presentation
fireside
chats
available
events
page
news
media
section
fortress
website
archived
replays
webcasts
available
approximately
days
following
presentation
fireside
chat
fortress
biotech
fortress
biotech
fortress
innovative
biopharmaceutical
company
recently
ranked
number
deloitte
technology
fast
annual
ranking
north
american
companies
technology
media
telecommunications
life
sciences
energy
tech
sectors
based
percentage
fiscal
year
revenue
growth
period
fortress
focused
acquiring
developing
commercializing
marketed
drugs
drug
candidates
company
five
marketed
prescription
pharmaceutical
products
programs
development
fortress
partners
partners
founded
holds
significant
minority
ownership
positions
product
candidates
span
six
areas
including
oncology
rare
diseases
gene
therapy
allow
create
value
shareholders
fortress
advances
diversified
pipeline
streamlined
operating
structure
fosters
efficient
drug
development
fortress
model
driven
business
development
team
focused
leveraging
significant
biopharmaceutical
industry
expertise
expand
company
portfolio
product
opportunities
fortress
established
partnerships
world
leading
academic
research
institutions
biopharmaceutical
companies
maximize
opportunity
full
potential
including
alexion
pharmaceuticals
astrazeneca
city
hope
fred
hutchinson
cancer
research
center
invagen
pharmaceuticals
subsidiary
cipla
limited
jude
children
research
hospital
nationwide
children
hospital
information
visit
statements
press
release
may
contain
statements
within
meaning
section
securities
act
section
securities
exchange
act
amended
used
throughout
press
release
words
us
may
refer
fortress
individually
together
one
partner
companies
dictated
context
statements
include
limited
statements
relating
growth
strategy
product
development
programs
statements
historical
facts
statements
based
management
current
expectations
subject
risks
uncertainties
could
negatively
affect
business
operating
results
financial
condition
stock
price
factors
could
cause
actual
results
differ
materially
currently
anticipated
include
risks
relating
growth
strategy
ability
obtain
perform
maintain
financing
strategic
agreements
relationships
risks
relating
results
research
development
activities
uncertainties
relating
preclinical
clinical
testing
risks
relating
timing
starting
completing
clinical
trials
dependence
suppliers
risks
relating
outbreak
potential
impact
employees
consultants
ability
complete
work
timely
manner
ability
obtain
additional
financing
favorable
terms
ability
attract
integrate
retain
key
personnel
early
stage
products
development
need
substantial
additional
funds
government
regulation
patent
intellectual
property
matters
competition
well
risks
described
securities
exchange
commission
filings
expressly
disclaim
obligation
undertaking
release
publicly
updates
revisions
statements
contained
herein
reflect
change
expectations
changes
events
conditions
circumstances
statement
based
except
may
required
law
claim
protection
safe
harbor
statements
contained
private
securities
litigation
reform
act
information
contained
herein
intended
reviewed
totality
stipulations
conditions
provisos
apply
given
piece
information
one
part
press
release
read
applying
mutatis
mutandis
every
instance
information
appearing
herein
company
contacts
jaclyn
jaffe
william
begien
fortress
biotech
ir
investor
relations
contact
daniel
ferry
lifesci
advisors
llc
daniel
media
relations
contact
tony
plohoros
degrees
tplohoros
